Skip to content
10-Q

Quarterly Report

Actinium Pharmaceuticals, Inc. ATNM

0001213900-25-110979

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 31.2M sh
Shares Diluted Q3 2025 · Sep 30, 2025 31.2M sh
Shares Diluted Q3 2025 · Sep 30, 2025 31.2M sh
Shares Diluted Q3 2025 · Sep 30, 2024 31.07M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.69M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$19.29M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$27.32M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $53.39M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $72.9M
Stockholders Equity Q3 2025 · Sep 30, 2025 $13.78M
Stockholders Equity Q3 2025 · Jun 30, 2025 $19.01M
Stockholders Equity Q3 2025 · Mar 31, 2025 $25.69M
Stockholders Equity Q3 2025 · Dec 31, 2024 $32.76M
Stockholders Equity Q3 2025 · Sep 30, 2024 $38.21M
Stockholders Equity Q3 2025 · Jun 30, 2024 $43.84M
Stockholders Equity Q3 2025 · Mar 31, 2024 $43.86M
Stockholders Equity Q3 2025 · Dec 31, 2023 $36.38M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.83M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.15M
Total Liabilities Q3 2025 · Sep 30, 2025 $42.37M
Total Liabilities Q3 2025 · Dec 31, 2024 $44.14M
Current Assets Q3 2025 · Sep 30, 2025 $54.37M
Current Assets Q3 2025 · Dec 31, 2024 $74.51M
Total Assets Q3 2025 · Sep 30, 2025 $56.15M
Total Assets Q3 2025 · Dec 31, 2024 $76.9M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.16
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.90
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.06
Eps Basic Q3 2025 · Sep 30, 2025 −$0.16
Eps Basic Q3 2025 · Sep 30, 2025 −$0.90
Eps Basic Q3 2025 · Sep 30, 2024 −$0.37
Eps Basic Q3 2025 · Sep 30, 2024 −$1.06
Sga Expense Q3 2025 · Sep 30, 2025 $1.53M
Sga Expense Q3 2025 · Sep 30, 2025 $13.1M
Sga Expense Q3 2025 · Sep 30, 2024 $2.83M
Sga Expense Q3 2025 · Sep 30, 2024 $9.38M
Rd Expense Q3 2025 · Sep 30, 2025 $4.25M
Rd Expense Q3 2025 · Sep 30, 2025 $16.83M
Rd Expense Q3 2025 · Sep 30, 2024 $9.77M
Rd Expense Q3 2025 · Sep 30, 2024 $25.23M
Net Income Q3 2025 · Sep 30, 2025 −$5.13M
Net Income Q3 2025 · Sep 30, 2025 −$27.95M
Net Income Q3 2025 · Jun 30, 2025 −$6.88M
Net Income Q3 2025 · Mar 31, 2025 −$15.94M
Net Income Q3 2025 · Sep 30, 2024 −$11.57M
Net Income Q3 2025 · Sep 30, 2024 −$31.59M
Net Income Q3 2025 · Jun 30, 2024 −$11.35M
Net Income Q3 2025 · Mar 31, 2024 −$8.67M
Operating Income Q3 2025 · Sep 30, 2025 −$5.69M
Operating Income Q3 2025 · Sep 30, 2025 −$29.83M
Operating Income Q3 2025 · Sep 30, 2024 −$12.6M
Operating Income Q3 2025 · Sep 30, 2024 −$34.62M
Revenue Q3 2025 · Sep 30, 2025 $90K
Revenue Q3 2025 · Sep 30, 2025 $90K
Capex Q3 2025 · Sep 30, 2024 $11K